Arribas J - Search Results

1

p95HER2-T cell bispecific antibody for breast cancer treatment.

Rius Ruiz I, Vicario R, Morancho B, Morales CB, Arenas EJ, Herter S, Freimoser-Grundschober A, Somandin J, Sam J, Ast O, Barriocanal ÁM, Luque A, Escorihuela M, Varela I, Cuartas I, Nuciforo P, Fasani R, Peg V, Rubio I, Cortés J, Serra V, Escriva-de-Romani S, Sperinde J, Chenna A, Huang W, Winslow J, Albanell J, Seoane J, Scaltriti M, Baselga J, Tabernero J, Umana P, Bacac M, Saura C, Klein C, Arribas J. Rius Ruiz I, et al. Among authors: arribas j. Sci Transl Med. 2018 Oct 3;10(461):eaat1445. doi: 10.1126/scitranslmed.aat1445. Sci Transl Med. 2018. PMID: 30282693 Free PMC article.

2

Pro-tumor necrosis factor-alpha processing activity is tightly controlled by a component that does not affect notch processing.

Merlos-Suárez A, Fernández-Larrea J, Reddy P, Baselga J, Arribas J. Merlos-Suárez A, et al. Among authors: arribas j. J Biol Chem. 1998 Sep 18;273(38):24955-62. doi: 10.1074/jbc.273.38.24955. J Biol Chem. 1998. PMID: 9733803 Free article.

3

The cytoplasmic carboxy-terminal amino acid determines the subcellular localization of proTGF-(alpha) and membrane type matrix metalloprotease (MT1-MMP).

Ureña JM, Merlos-Suárez A, Baselga J, Arribas J. Ureña JM, et al. Among authors: arribas j. J Cell Sci. 1999 Mar;112 ( Pt 6):773-84. doi: 10.1242/jcs.112.6.773. J Cell Sci. 1999. PMID: 10036228

4

Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells.

Codony-Servat J, Albanell J, Lopez-Talavera JC, Arribas J, Baselga J. Codony-Servat J, et al. Among authors: arribas j. Cancer Res. 1999 Mar 15;59(6):1196-201. Cancer Res. 1999. PMID: 10096547

5

Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells.

Molina MA, Codony-Servat J, Albanell J, Rojo F, Arribas J, Baselga J. Molina MA, et al. Among authors: arribas j. Cancer Res. 2001 Jun 15;61(12):4744-9. Cancer Res. 2001. PMID: 11406546

6

Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme.

Merlos-Suárez A, Ruiz-Paz S, Baselga J, Arribas J. Merlos-Suárez A, et al. Among authors: arribas j. J Biol Chem. 2001 Dec 21;276(51):48510-7. doi: 10.1074/jbc.M103488200. Epub 2001 Oct 12. J Biol Chem. 2001. PMID: 11600492 Free article.

7

Mechanism of action of trastuzumab and scientific update.

Baselga J, Albanell J, Molina MA, Arribas J. Baselga J, et al. Among authors: arribas j. Semin Oncol. 2001 Oct;28(5 Suppl 16):4-11. doi: 10.1016/s0093-7754(01)90276-3. Semin Oncol. 2001. PMID: 11706390 Review.

8

TACE is required for the activation of the EGFR by TGF-alpha in tumors.

Borrell-Pagès M, Rojo F, Albanell J, Baselga J, Arribas J. Borrell-Pagès M, et al. Among authors: arribas j. EMBO J. 2003 Mar 3;22(5):1114-24. doi: 10.1093/emboj/cdg111. EMBO J. 2003. PMID: 12606576 Free PMC article.

9

ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells.

Anido J, Matar P, Albanell J, Guzmán M, Rojo F, Arribas J, Averbuch S, Baselga J. Anido J, et al. Among authors: arribas j. Clin Cancer Res. 2003 Apr;9(4):1274-83. Clin Cancer Res. 2003. PMID: 12684395

10

Treating cancer's kinase 'addiction'.

Baselga J, Arribas J. Baselga J, et al. Among authors: arribas j. Nat Med. 2004 Aug;10(8):786-7. doi: 10.1038/nm0804-786. Nat Med. 2004. PMID: 15286778 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

753 results

Search Page

Filters